Bio-Techne (TECH) Interest Coverage Ratio Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 40.09% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | -18.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.79% |
| Dec 31, 2025 | -4.52% |
| Sep 30, 2025 | 3.01% |
| Jun 30, 2025 | -32.77% |
| Mar 31, 2025 | -18.99% |
| Dec 31, 2024 | 0.91% |
| Sep 30, 2024 | -0.31% |
| Jun 30, 2024 | -4.30% |
| Mar 31, 2024 | -13.45% |
| Dec 31, 2023 | -14.86% |
| Sep 30, 2023 | 0.89% |
| Jun 30, 2023 | 44.21% |
| Mar 31, 2023 | 76.60% |
| Dec 31, 2022 | 55.98% |
| Sep 30, 2022 | 32.54% |
| Jun 30, 2022 | 60.82% |
| Mar 31, 2022 | 61.44% |
| Dec 31, 2021 | 54.42% |
| Sep 30, 2021 | 55.66% |
| Jun 30, 2021 | 63.91% |
| Mar 31, 2021 | 15.30% |
| Dec 31, 2020 | 11.15% |
| Sep 30, 2020 | -1.42% |
| Jun 30, 2020 | -22.85% |
| Mar 31, 2020 | -69.87% |
| Dec 31, 2019 | -66.82% |
| Sep 30, 2019 | -76.81% |
| Jun 30, 2019 | -56.26% |
| Mar 31, 2019 | -55.39% |
| Dec 31, 2018 | -59.84% |
| Sep 30, 2018 | -58.50% |
| Jun 30, 2018 | -27.83% |
| Mar 31, 2018 | -43.88% |
| Dec 31, 2017 | -49.22% |
| Sep 30, 2017 | -53.20% |